Delivery Order 75N98020D00049-75N92026F00007
- The National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH) awarded a delivery order against its NIH Patent Legal Services master indefinite-delivery/indefinite-quantity contract to Klarquist Sparkman, LLP. Valued at $11,081, this firm fixed price order requires Klarquist Sparkman to file a national stage patent application in Europe to pursue patent rights on behalf of NHLBI. Performance will take place in Portland, Oregon over a period of nine months...
- The National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), awarded a $15,078 firm fixed-price delivery order contract to the intellectual property law firm Klarquist Sparkman, LLP. Under this contract, Klarquist Sparkman will prepare and file a provisional patent application to secure protection for an invention described in document E-264-2023-1-US-01. The contract was awarded without any set-aside designation and is part of the larger NIH...
- The National Heart, Lung and Blood Institute of the National Institutes of Health awarded a $14,274 firm fixed price delivery order to Klarquist Sparkman, LLP under the NIH Patent Legal Services master IDIQ contract. The delivery order requires Klarquist Sparkman to file a provisional patent application on behalf of the NHLBI to establish priority for an invention covering enhanced HLA-independent T cell receptors modified T cells targeting a CT-RCC-1 peptide derived to treat cancer. Work will...
- This federal contract award was issued by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to the intellectual property law firm Klarquist Sparkman, LLP. The $11,087 firm fixed-price contract requires the vendor to review a patent office action and develop a strategy to secure patent protection for an invention related to the NHLBI's research program. This award is issued as a delivery order under Klarquist Sparkman's $115 million NIH...
- The National Institutes of Health National Heart Lung and Blood Institute awarded a $10,862 firm fixed price delivery order against the NIH Patent Legal Services master IDIQ contract to Klarquist Sparkman, LLP. Under the order, Klarquist Sparkman will file a fully enabled provisional patent application by a potential due date to secure patent protection for NIH reference number E-119-2022-0-US-01. The National Heart Lung and Blood Institute is part of the Department of Health and Human...
- This federal contract award was issued by the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health (NIH), to the intellectual property law firm Klarquist Sparkman, LLP. The $13,686 firm fixed-price contract requires the firm to draft and file a Patent Cooperation Treaty (PCT) application based on a priority case to secure patent protection for an invention. Klarquist Sparkman, LLP is a for-profit organization specializing in patent, trademark, and...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded Klarquist Sparkman, LLP a $4,920.53 delivery order against the NIH Patent Legal Services master indefinite-delivery/indefinite-quantity contract. Klarquist Sparkman, LLP will provide patent legal services to support the agency's programs from its office in Portland, Oregon over a three-year period ending in May 2023. No subcontractors or set-aside designations were...
- This is a Delivery Order awarded by the National Heart, Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Klarquist Sparkman, LLP, a law firm specializing in patent, trademark, and copyright services for federal agencies. The contract, valued at $12,910.00, requires Klarquist Sparkman to prepare and file a national stage patent application in Europe to secure patent protection for a technology described in E-119-2022-0-EP-01. This work is being performed under...
- The National Heart, Lung and Blood Institute, part of the National Institutes of Health within the Department of Health and Human Services, awarded a $10,714 delivery order to Klarquist Sparkman, LLP. The delivery order was issued against the NIH Patent Legal Services master IDIQ contract vehicle to require the filing of a national stage patent application in Europe in order to perfect patent rights claiming a natural killer cell immunotherapy against cancer. Klarquist Sparkman, LLP will perform...
- This is a firm fixed-price delivery order awarded by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to the intellectual property law firm Klarquist Sparkman, LLP. The $11,574 contract requires the vendor to perform a conflict of interest check in order to secure patent protection for an invention described in a patent application. This contract is not associated with a set-aside program. Klarquist Sparkman is an experienced provider of...
- NIH Patent Legal ServicesMaster IDIQ
- 75N98020D00049Indefinite Delivery Contract
- 75N98020D00049-75N92026F00007Delivery Order
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $17,549 firm fixed-price delivery order to Klarquist Sparkman, LLP, a Portland, Oregon-based intellectual property law firm specializing in patent services. This delivery order, issued under the NIH Patent Legal Services master IDIQ contract, requires the contractor to prepare and file a national stage patent application in a selected country to secure patent protection for a federally funded invention. The work is scheduled for completion by December 3, 2026, and no set-aside designation was applied to this award, indicating the vendor competed based on its specialized patent legal expertise. This delivery order represents a routine task order under Klarquist Sparkman's larger $115 million multiple-award IDIQ contract with the National Institutes of Health, which provides comprehensive patent legal services across various NIH institutes and the Centers for Disease Control and Prevention. The firm has established itself as a trusted provider of intellectual property support for biomedical research emerging from federally funded programs, with particular expertise in biotechnology and medical innovations. The international patent filing work under this delivery order supports NHLBI's mission to advance cardiovascular, lung, and blood disease research by protecting the intellectual property rights of inventions developed through institute-funded research initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.5k | 12/5/25 |